ZOMライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (27 4月 2024 @ 05:00):

Stats
本日の出来高	2.71M
平均出来高	4.75M
時価総額	130.33M
EPS	$0 ( 2024-03-20 )
次の収益日	( $0 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-3.32
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2023-12-15	Powers Johnny D	Buy	100 000	Common Stock, without par value
2023-12-15	Powers Johnny D	Buy	100 000	Common Stock, without par value
2023-11-17	Powers Johnny D	Buy	100 000	Common Stock, without par value
2023-11-17	Heaton Larry C Ii	Buy	100 000	Common Stock, without par value
2023-11-15	Powers Johnny D	Buy	150 000	Common Stock, without par value

INSIDER POWER
94.09
Last 93 transactions
Buy: 92 487 495 \| Sell: 14 772 509

ボリューム相関

長: 0.28 (neutral)

短: -0.38 (neutral)

Signal:(55.544) Neutral

Zomedica Pharmaceuticals 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Zomedica Pharmaceuticals 相関 - 通貨/商品

0.00
( neutral )

Zomedica Pharmaceuticals 財務諸表

Annual	2024
収益:	$25.19M
総利益:	$17.32M (68.76 %)
EPS:	$-0.0352

FY	2024
収益:	$25.19M
総利益:	$17.32M (68.76 %)
EPS:	$-0.0352

FY	2023
収益:	$18.93M
総利益:	$13.65M (72.12 %)
EPS:	$-0.0174

FY	2022
収益:	$4.13M
総利益:	$3.05M (73.89 %)
EPS:	$-0.0192

Financial Reports:

No articles found.

Zomedica Pharmaceuticals

Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment of various musculoskeletal issues, such as broken bones, tendonitis, and torn ligaments in horses and small animals. It has collaboration agreements with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and Seraph Biosciences, Inc. for development and markets a novel pathogen detection system. The company was formerly known as Zomedica Pharmaceuticals Corp. and changed its name to Zomedica Corp. in October 2020. Zomedica Corp. was founded in 2015 and is headquartered in Ann Arbor, Michigan.